A Silicon Valley venture capital fund on Wednesday pledged to back three new ventures to combat global infectious disease in a $200m investment vehicle it had previously created called the Pandemic Preparedness Fund.

Kleiner Perkins Caufield & Byers said it would take stakes in companies working on vaccines, anti-viral drugs, diagnostics and detection, and help ensure the products were made affordable in the developing world.